Categories Analysis, Technology

After the recent rally, is Facebook (FB) stock a buy right now?

Advertising revenue is expected to benefit from the ongoing shift to e-commerce and the growing consumption of online content

The sharp increase in the consumption of online content after markets went into lock-down mode came as a boon for internet companies like Facebook, Inc. (NASDAQ: FB). Defying concerns that the unusually high ad demand could be temporary, the social media giant stayed on the growth path even after the markets started reopening amid the vaccination drive. Renewed hopes of a faster economic recovery have added to the positive sentiment.

The company’s stock traded at an all-time high on Tuesday, after setting new records regularly over the years. The stock, which is considered a safe bet, remains as attractive as ever before — for those who can afford it. Though the valuation looks high, it is deemed appropriate at the current price. But, the shares are probably headed for a bigger rally this year – an estimated growth of around 12%. That is enough reason to grab FB before the next quarterly report, for the uptrend is expected to gain steam post-earnings.

Bullish View

Facebook’s first-quarter 2021 earnings release is slated for April 28 after the regular trading hours, amid high expectations as usual. Experts see earnings growing about 38% to $2.36 per share, on revenues of $23.54 billion.

FACEBOOK Q4 2020 earnings

Road Ahead

Going forward, advertising revenue should benefit from the ongoing shift to e-commerce and the growing consumption of online content. While it is estimated that the trend would continue even after normalcy returns to markets, it is too early to predict how things would emerge post-COVID. The continuing uncertainty does not bode well for Facebook and its peers in the technology industry. In addition, regulatory scrutiny and looming legal action for alleged misinformation on the platform and breach of privacy norms remain a major risk as far as the company’s future prospects are concerned.

“2021 has a lot of unknowns. We don’t know when vaccines are going to be widely available, when our teams will be back in the office or when our lives are going to start feeling normal again, but what I do know is that we are going to keep investing in and innovating on the big themes that I discussed here in order to put more power in the hands of people and small businesses. I personally believe that technology can unlock progress and opportunity and that the full story of the Internet has not yet been written,” said Facebook’s CEO Mark Zuckerberg during his interaction with analysts at the Q4 earnings conference call.

Strong User Base

At the end of fiscal 2020, Facebook had around 2.8 billion monthly active users, after consistent growth over the years. The solid user engagement translated into a spike in ad revenues in the final months of the year when total revenue grew more than a third to about $28 billion. As a result, fourth-quarter earnings climbed 52% to $3.88 per share.


Read management/analysts’ comments on Facebook’s Q4 2020 earnings


The stock once again crossed the $300-mark this week, driving up the company’s market cap to about $879 billion. In the past three months alone the shares gained about 15%, outperforming the S&P 500 index. They closed the last trading session up 3%.

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top